Top Markets
#1 MowCat MowCat +49.05%
#2 Velvet Velvet +36.37%
#3 Audiera Audiera +22.76%
#4 Derive Derive +20.53%
#5 Bermuda Shorts Bermuda Shorts +18.78%
#6 Quack AI Quack AI +18.60%
#7 MarsCoin MarsCoin +16.83%
#8 aPriori aPriori +15.97%
#9 Biconomy Biconomy +13.82%
#10 Cross Cross +11.62%
Coin of the day
MowCat MowCat
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Medigene AG Medigene AG

Medigene AG

MDG1
Rang în acțiuni #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Preț acțiune
$0.14942078
Ultima sincronizare: 2025-05-15
Capitalizare de piață
$3.86M
Schimbare (1 zi)
0.10%
Schimbare (1 an)
0.00%
Țară
DE
Tranzacționează Medigene AG (MDG1)

Categorie

Healthcare
Raport P/B pentru Medigene AG (MDG1)
Raport P/B la data de August 2026 TTM: 0.08
Conform celor mai recente rapoarte financiare și prețului acțiunilor Medigene AG, raportul P/B actual (TTM) este 0.08. La sfârșitul anului 2022, compania avea un P/B de 1.33.
Istoricul raportului P/B pentru Medigene AG din 2004 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 0.08 -95.37%
2023 1.68 25.83%
2022 1.33 -14.69%
2021 1.56 -3.33%
2020 1.62 35.42%
2019 1.19 -67.18%
2018 3.64 -42.42%
2017 6.32 5.15%
2016 6.01 95.80%
2015 3.07 75.28%
2014 1.75 -0.10%
2013 1.75 9.93%
2012 1.60 112.55%
2011 0.75 -57.92%
2010 1.78 -24.51%
2009 2.36 4.86%
2008 2.25 35.63%
2007 1.66 15.41%
2006 1.44 -51.96%
2005 3.00 55.45%
2004 1.93 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 8,051.54%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 7,922.24%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 4,348.84%
BE